Results 111 to 120 of about 191,179 (159)
Some of the next articles are maybe not open access.

Pyruvate kinase activators for treatment of pyruvate kinase deficiency

Hematology, 2023
Abstract Pyruvate kinase (PK) deficiency is a congenital hemolytic anemia with wide-ranging clinical symptoms and complications associated with significant morbidity and reduced health-related quality of life in both children and adults.
openaire   +2 more sources

Pyruvate Metabolism and Control: Factors Affecting Pyruvic Carboxylase Activity

Science, 1964
Pyruvic carboxylase activated by acetyl coenzyme A is highly active in the mitochondria of rodent liver, and its activity is increased in fasting and alloxan diabetes. In conjunction with acyl carboxylase activated by di- and tricarboxylic acid, it forms a reciprocating control network.
A D, FREEDMAN, L, KOHN
openaire   +2 more sources

Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex

Journal of Inherited Metabolic Disease, 1996
SummaryThe most common defect associated with deficiency of the pyruvate dehydrogenase (PDH) complex occurs in the E1 component, specifically due to mutations in the X‐linked E1α gene. Clinical sequelae of these mutations, which range from severe neonatal lactic acidosis to carbohydrate‐sensitive ataxia, can be different in males and females depending ...
B H, Robinson   +3 more
openaire   +2 more sources

Assays of Pyruvate Dehydrogenase Complex and Pyruvate Carboxylase Activity

2011
Pyruvate dehydrogenase complex (PDC) and pyruvate carboxylase (PC) are mitochondrial enzymes that provide the initial steps of the two main alternatives for pyruvate metabolism: oxidative decarboxylation vs. anaplerotic carboxylation, gluconeogenesis, and glycerogenesis.
Douglas, Kerr   +2 more
openaire   +2 more sources

Pyruvate Carboxylase and Pyruvate Dehydrogenase Deficiency

2014
Pyruvate carboxylase and pyruvate dehydrogenase deficiency are the most common disorders in pyruvate metabolism and almost always affect the central nervous system. The severity and the clinical phenotypes vary, with a range from overwhelming neonatal lactic acidosis and early death to milder presentations.
openaire   +1 more source

[Pyruvate kinase deficiency].

Nihon rinsho. Japanese journal of clinical medicine, 1974
PK deficiency is the most common and well characterized erythroenzymopathy in the Embden-Meyerhof glycolytic pathway associated with hereditary hemolytic anemia. History of discovery, clinical features, biochemical studies, as well as recent studies on molecular level were reviewed, with a stress on our own studies. As reference materials, Tables 2 and
openaire   +3 more sources

The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Cell Metabolism, 2021
Ahmad A Cluntun   +2 more
exaly  

Pyruvate Carboxylase

1984
P V, Attwood, D B, Keech
openaire   +2 more sources

The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function

Cell Metabolism, 2022
Alison Jaccard   +2 more
exaly  

Pyruvate

2003
Melanie Johns Cupp, Timothy S. Tracy
openaire   +2 more sources

Home - About - Disclaimer - Privacy